loading
Heron Therapeutics Inc stock is traded at $1.06, with a volume of 469.16K. It is down -4.46% in the last 24 hours and down -40.88% over the past month. Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.
See More
Previous Close:
$1.12
Open:
$1.1
24h Volume:
469.16K
Relative Volume:
0.27
Market Cap:
$175.63M
Revenue:
$137.74M
Net Income/Loss:
$-27.97M
P/E Ratio:
-0.906
EPS:
-1.17
Net Cash Flow:
$-9.61M
1W Performance:
-13.71%
1M Performance:
-40.88%
6M Performance:
-68.90%
1Y Performance:
-18.32%
1-Day Range:
Value
$1.05
$1.12
1-Week Range:
Value
$1.05
$1.255
52-Week Range:
Value
$1.04
$3.93

Heron Therapeutics Inc Stock (HRTX) Company Profile

Name
Name
Heron Therapeutics Inc
Name
Phone
(858) 251-4400
Name
Address
4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA
Name
Employee
126
Name
Twitter
Name
Next Earnings Date
2024-11-12
Name
Latest SEC Filings
Name
HRTX's Discussions on Twitter

Compare HRTX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
HRTX 1.0612 175.63M 137.74M -27.97M -9.61M -1.17
VRTX 446.64 115.74B 10.63B -479.80M -1.35B 13.33
REGN 739.77 81.65B 13.85B 4.65B 3.32B 35.06
ARGX 588.98 34.86B 1.86B -40.29M -1.28B -4.16
ALNY 249.89 32.09B 2.09B -332.26M 16.06M -4.14
BNTX 103.94 24.49B 3.30B -501.07M 1.03B 11.54

Heron Therapeutics Inc Stock (HRTX) Upgrades & Downgrades

Date Action Analyst Rating Change
May-27-20 Initiated Guggenheim Buy
Feb-20-20 Reiterated Needham Buy
Jan-16-19 Reiterated Needham Buy
Apr-05-18 Initiated Evercore ISI Outperform
Mar-19-18 Reiterated Mizuho Buy
Mar-01-18 Reiterated Needham Buy
Jan-03-18 Initiated Leerink Partners Outperform
Sep-27-17 Initiated Northland Capital Outperform
Feb-27-17 Initiated Needham Buy
Oct-26-16 Initiated Aegis Capital Buy
Sep-06-16 Resumed Lake Street Buy
May-03-16 Initiated Cantor Fitzgerald Buy
Dec-10-15 Initiated Lake Street Buy
Sep-23-15 Reiterated Leerink Partners Outperform
Sep-02-15 Initiated BofA/Merrill Buy
Aug-03-15 Reiterated Brean Capital Buy
Jun-30-15 Reiterated JMP Securities Mkt Outperform
Jun-19-15 Reiterated Leerink Partners Outperform
Aug-07-14 Initiated Noble Financial Buy
View All

Heron Therapeutics Inc Stock (HRTX) Latest News

pulisher
03:39 AM

Heron Therapeutics (NASDAQ:HRTX) Downgraded by StockNews.com to "Hold" - MarketBeat

03:39 AM
pulisher
Nov 20, 2024

Heron Therapeutics (HRTX) Reports Q3 Loss, Misses Revenue Estimates - MSN

Nov 20, 2024
pulisher
Nov 20, 2024

Heron Therapeutics Q3 2024 Earnings Preview - MSN

Nov 20, 2024
pulisher
Nov 19, 2024

Heron Therapeutics Inc (NASDAQ: HRTX) Declines -1.68%: This $177.95 million Stock Could Go Down -669.23% - Stocks Register

Nov 19, 2024
pulisher
Nov 18, 2024

Short Interest in Heron Therapeutics, Inc. (NASDAQ:HRTX) Declines By 6.0% - MarketBeat

Nov 18, 2024
pulisher
Nov 17, 2024

Northland Capmk Has Pessimistic View of HRTX Q4 Earnings - Defense World

Nov 17, 2024
pulisher
Nov 15, 2024

Equities Analysts Set Expectations for HRTX Q4 Earnings - MarketBeat

Nov 15, 2024
pulisher
Nov 15, 2024

Heron Therapeutics (NASDAQ:HRTX) Raised to Buy at StockNews.com - Defense World

Nov 15, 2024
pulisher
Nov 14, 2024

Heron Therapeutics Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Simply Wall St

Nov 14, 2024
pulisher
Nov 13, 2024

Heron Therapeutics, Inc. (NASDAQ:HRTX) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 13, 2024
pulisher
Nov 13, 2024

Needham & Company LLC Has Lowered Expectations for Heron Therapeutics (NASDAQ:HRTX) Stock Price - MarketBeat

Nov 13, 2024
pulisher
Nov 13, 2024

Why Investors Shouldn't Be Surprised By Heron Therapeutics, Inc.'s (NASDAQ:HRTX) 30% Share Price Plunge - Simply Wall St

Nov 13, 2024
pulisher
Nov 13, 2024

Heron Therapeutics Inc (HRTX) Quarterly 10-Q Report - Quartzy

Nov 13, 2024
pulisher
Nov 13, 2024

Investors Don't See Light At End Of Heron Therapeutics, Inc.'s (NASDAQ:HRTX) Tunnel And Push Stock Down 30% - Simply Wall St

Nov 13, 2024
pulisher
Nov 13, 2024

Earnings call: Heron Therapeutics projects higher Q4 revenue By Investing.com - Investing.com UK

Nov 13, 2024
pulisher
Nov 12, 2024

Heron Therapeutics Reports Q3 2024 Results and Narrows Guidance - TipRanks

Nov 12, 2024
pulisher
Nov 12, 2024

Heron Therapeutics: Q3 Earnings Snapshot - CT Insider

Nov 12, 2024
pulisher
Nov 12, 2024

Heron Therapeutics (HRTX) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance

Nov 12, 2024
pulisher
Nov 12, 2024

U.S. Stock market most volatile stocks: Neuronetics(-47.27%), Heron Therapeutics(-20.15%) and LogicMark(+94.36%) in early trading - Business Upturn

Nov 12, 2024
pulisher
Nov 12, 2024

Heron Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 12, 2024
pulisher
Nov 12, 2024

Heron Therapeutics reports Q3 EPS (3c), consensus (3c) - TipRanks

Nov 12, 2024
pulisher
Nov 12, 2024

Heron Therapeutics Announces Third Quarter 2024 Financial Results and Narrows Financial Guidance - PR Newswire

Nov 12, 2024
pulisher
Nov 10, 2024

Heron Therapeutics (HRTX) Set to Announce Earnings on Tuesday - Defense World

Nov 10, 2024
pulisher
Nov 07, 2024

Unveiling Heron Therapeutics (HRTX) Q3 Outlook: Wall Street Estimates for Key Metrics - Yahoo Finance

Nov 07, 2024
pulisher
Nov 05, 2024

Heron Therapeutics (HRTX) Scheduled to Post Quarterly Earnings on Tuesday - MarketBeat

Nov 05, 2024
pulisher
Nov 05, 2024

Positive Signs As Multiple Insiders Buy Heron Therapeutics Stock - Yahoo Finance UK

Nov 05, 2024
pulisher
Nov 04, 2024

Heron Therapeutics Strengthens Leadership with New Board Appointment - TipRanks

Nov 04, 2024
pulisher
Nov 04, 2024

Heron Therapeutics Announces Appointment of Michael Kaseta to Board of Directors - StockTitan

Nov 04, 2024
pulisher
Oct 31, 2024

Bunion Market Forecasted to Surge in Coming Years, 2024-2034 Analysis by DelveInsight | Heron Therapeutics, Lotus Clinical Research, Cali Pharma, Grünenthal GmbH, Pacira Pharma, Inc, Mallinckrodt - The Globe and Mail

Oct 31, 2024
pulisher
Oct 29, 2024

Heron Therapeutics to Report Third Quarter 2024 Financial Results On Tuesday, November 12, 2024 - Longview News-Journal

Oct 29, 2024
pulisher
Oct 26, 2024

SG Americas Securities LLC Cuts Stake in Heron Therapeutics, Inc. (NASDAQ:HRTX) - Defense World

Oct 26, 2024
pulisher
Oct 21, 2024

Antinauseants Market Insights, Forecast to 2031Heron - openPR

Oct 21, 2024
pulisher
Oct 20, 2024

The Manufacturers Life Insurance Company Acquires 6,328 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX) - Defense World

Oct 20, 2024
pulisher
Oct 16, 2024

Heron Therapeutics, Inc. (NASDAQ:HRTX) Short Interest Update - MarketBeat

Oct 16, 2024
pulisher
Oct 15, 2024

Heron Therapeutics Inc (HRTX) deserves deeper analysis - US Post News

Oct 15, 2024
pulisher
Oct 14, 2024

Investor’s Toolkit: Key Ratios for Assessing Heron Therapeutics Inc (HRTX)’s Performance - The Dwinnex

Oct 14, 2024
pulisher
Oct 12, 2024

Heron Therapeutics, Inc. (NASDAQ:HRTX) Shares Sold by Millennium Management LLC - Defense World

Oct 12, 2024
pulisher
Oct 11, 2024

Heron Therapeutics, Inc. (NASDAQ:HRTX) Shares Bought by Congress Park Capital LLC - MarketBeat

Oct 11, 2024
pulisher
Oct 10, 2024

Heron Therapeutics Reaffirms Availability and Ample Supply of CINVANTI®, SUSTOL®, and APONVIE® as Alternatives During the Potential Shortage of Intravenous Fluids - The Malaysian Reserve

Oct 10, 2024
pulisher
Oct 09, 2024

Its Stock Has Paid Off Big Time For Heron Therapeutics Inc - SETE News

Oct 09, 2024
pulisher
Oct 09, 2024

AQR Capital Management LLC Raises Holdings in Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat

Oct 09, 2024
pulisher
Oct 08, 2024

Heron Therapeutics Inc Inc. (HRTX) Price Performance: The Role of Supply and Demand - The InvestChronicle

Oct 08, 2024
pulisher
Oct 08, 2024

Can you now get a good deal on Heron Therapeutics Inc’s shares? - US Post News

Oct 08, 2024
pulisher
Oct 06, 2024

Squarepoint Ops LLC Purchases 286,160 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat

Oct 06, 2024
pulisher
Oct 03, 2024

Buying Buzz: Heron Therapeutics Inc [HRTX] EVP, Chief Development Officer Forbes William P purchases 25,000 shares of the company – Knox Daily - Knox Daily

Oct 03, 2024
pulisher
Oct 03, 2024

HRTX’s Stock Market Pendulum: Swinging Between Gains and Losses - The InvestChronicle

Oct 03, 2024
pulisher
Oct 03, 2024

When Can We Expect A Profit From Heron Therapeutics, Inc. (NASDAQ:HRTX)? - Simply Wall St

Oct 03, 2024
pulisher
Oct 02, 2024

Get in on Heron Therapeutics Inc’s (HRTX) buy-in window today! - SETE News

Oct 02, 2024
pulisher
Oct 02, 2024

Heron Therapeutics, Inc.'s (NASDAQ:HRTX) Path To Profitability - Yahoo Finance

Oct 02, 2024

Heron Therapeutics Inc Stock (HRTX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$70.68
price down icon 0.42%
$18.62
price up icon 0.16%
$36.06
price down icon 1.68%
$364.60
price up icon 0.01%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Cap:     |  Volume (24h):